Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins as immunosuppressive agents.

J A Kobashigawa1

  • 1Division of Cardiology University of California at Los Angeles Medical Center 100 UCLA Medical Plaza, #630 Los Angeles, CA 90095.

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|July 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review.

Transplantation proceedings·2017
Same author

Combined Heart and Kidney Transplantation: A 23-Year Experience.

Transplantation proceedings·2017
Same author

Tacrolimus-associated Diffuse Gastrointestinal Ulcerations and Pathergy: A Case Report.

Transplantation proceedings·2017
Same author

Report from a forum on US heart allocation policy.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy.

Transplantation proceedings·2014
Same author

Everolimus in heart transplantation: does it finally have a home?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014

Statins may offer immunosuppressive benefits in organ transplantation by repressing major histocompatibility complex class II (MHC-II) expression, potentially reducing T-lymphocyte activation and improving transplant outcomes.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Cardiovascular Research

Background:

  • Cardiac allograft vasculopathy is a major cause of mortality after heart transplantation.
  • This accelerated atherosclerosis affects various transplanted organs.
  • Hyperlipidemia is a significant risk factor, and statins have shown potential benefits.

Purpose of the Study:

  • To elucidate the specific immunosuppressive mechanism of statins in organ transplantation.
  • To investigate the effect of statins on major histocompatibility complex class II (MHC-II) expression.
  • To understand how statins impact T-lymphocyte activation.

Main Methods:

  • Experiments monitored cell surface expression using fluorescence-activated cell sorting and immunofluorescence.

Related Experiment Videos

  • Messenger RNA (mRNA) levels of MHC-II were analyzed.
  • Studies included various cell types, including primary human cells and established cell lines.

    • Main Results:

    • Statins were found to repress the induction of MHC-II by interferon-gamma.
    • This repression subsequently inhibited the activation of T-lymphocytes.
    • Effects were observed across multiple cell types, including smooth muscle cells and fibroblasts.

    Conclusions:

    • The study provides a scientific rationale for using statins as adjunct immunosuppressive agents.
    • Statins demonstrate a mechanism that supports their use in organ transplant recipients.
    • Further supports clinical and laboratory findings on statin benefits in transplantation.